SCHEMBL42359

SCHEMBL42359

CCS(=O)(=O)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11030516 0.96
Hydrochloric Acid SCHEMBL28140997 0.96
SCHEMBL4922033 0.77
SCHEMBL861862 0.77
Trifluoroacetic Acid SCHEMBL29021584 0.77 ALDH1A1 (0.36)
SCHEMBL42331 0.76
SCHEMBL10865868 0.74
Hydrochloric Acid SCHEMBL622579 0.74
SCHEMBL241832 0.72 CA1 (0.35)
SCHEMBL604854 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112739701-B Fused pyrimidine skeleton sulfonamide derivative with inhibition effect of epidermal growth factor receptor mutation 韩美药品株式会社 2024-02-13 CN claimed
CN-111386266-B Pyrimidine derivatives having cancer cell growth inhibiting effect and pharmaceutical compositions containing the same 昂科比克斯有限公司 2023-08-04 CN claimed
EP-2694505-B1 HSP90 INHIBITORS SLOAN KETTERING INST CANCER RES (US) 2022-04-27 EP claimed
US-20210198203-A1 COMPOUNDS, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED 2021-07-01 US claimed
EP-3458455-B1 NOVEL PYRAZINE COMPOUNDS WITH OXYGEN, SULFUR AND NITROGEN LINKER FOR THE TREATMENT OF INFECTIOUS DISEASES HOFFMANN LA ROCHE (CH) 2021-06-16 EP claimed
US-10604527-B2 Pyrazine compounds for the treatment of hepatitis B infection HOFFMANN-LA ROCHE INC. (US) 2020-03-31 US claimed
WO-2020060268-A1 NOVEL SULFONAMIDE DERIVATIVE WITH FUSED PYRIMIDINE SKELETON, HAVING EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION INHIBITORY EFFECT 한미약품 주식회사 2020-03-26 WO claimed
US-20190352267-A1 COMPOUNDS, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED 2019-11-21 US claimed
US-20190185476-A1 NOVEL PYRAZINE COMPOUNDS WITH OXYGEN SULFUR AND NITROGEN LINKER FOR THE TREATMENT OF INFECTIOUS DISEASES HOFFMANN-LA ROCHE INC. (US) 2019-06-20 US claimed
EP-3458455-A1 NOVEL PYRAZINE COMPOUNDS WITH OXYGEN, SULFUR AND NITROGEN LINKER FOR THE TREATMENT OF INFECTIOUS DISEASES H. Hoffnabb-La Roche Ag (CH) 2019-03-27 EP claimed
WO-1993021178-A1 INDOLE DERIVATIVES AS 5-HT1-LIKE AGONISTS PFIZER LIMITED (GB) 1993-10-28 WO claimed
EP-0519235-A1 Preparation of alkanesulfonamides ELF ATOCHEM NORTH AMERICA, INC. (US) 1992-12-23 EP claimed
US-5166431-A Reacting ammonia, methylamine, or dimethylamine with alkanesulfonyl halide in cyclic saturated ether; removal of amine salt by-product ELF ATOCHEM NORTH AMERICA, INC. (US) 1992-11-24 US claimed
EP-0495594-A1 Sulphonamide derivatives ZENECA LIMITED (GB) 1992-07-22 EP claimed
EP-0167107-B1 PROCESS FOR THE MANUFACTURE OF AQUEOUS, FLUID PREPARATIONS OF REACTIVE DYES WITH A LOW SALT CONTENT HOECHST AKTIENGESELLSCHAFT (DE) 1991-05-08 EP claimed
US-4981864-A ANTICOAGULANTS BOEHRINGER MANNEHIM GMBH (DE) 1991-01-01 US claimed
CN-85105802-B Process for preparing low-salt aqueous preparations of fibre-reactive dyes 赫司特公司 1988-07-20 CN claimed
EP-0074894-B1 PROCESS FOR THE PURIFICATION OF A GASEOUS MIXTURE CONTAINING UNDESIRABLE GASEOUS COMPOUNDS COMPAGNIE FRANCAISE DE RAFFINAGE Société anonyme dite: (FR) 1985-01-02 EP claimed
EP-0094239-A2 1,3-Dioxan-5-ylalkenoic acids IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-11-16 EP claimed
US-4170547-A SOLVENT EXTRACTION COMPAGNIE FRANCAISE DE RAFFINAGE (FR) 1979-10-09 US claimed